Theodore Alan Huizenga
SVP, Chief Accounting Officer · Ultragenyx Pharmaceutical Inc.
- 2024
- Sep 15, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Theodore Alan Huizenga files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Emil D. Kakkis - $1.24M in RARE purchases and sales in the last 12 months
- Howard Horn - $1.08M in RARE purchases and sales in the last 12 months
- Karah Herdman Parschauer - $488K in RARE purchases and sales in the last 12 months
- Erik Harris - $240K in RARE purchases and sales in the last 12 months
- John Richard Pinion - $229K in RARE purchases and sales in the last 12 months
- Eric Crombez - $169K in RARE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Theodore Alan Huizenga?
Theodore Alan Huizenga is a corporate insider, tracked as SVP, Chief Accounting Officer of Ultragenyx Pharmaceutical Inc. (RARE). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Theodore Alan Huizenga submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Theodore Alan Huizenga been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($64K) across all tracked filings.
